Oligodendrocyte Lineage In Alzheimer'S Disease is a cell type relevant to neurodegenerative disease research. This page covers its role in brain function, involvement in disease processes, and significance for therapeutic strategies.
Oligodendrocyte Lineage Cells in Alzheimer's Disease exhibit distinct vulnerabilities and adaptive responses that contribute to white matter degeneration and cognitive decline. Both oligodendrocyte precursor cells (OPCs) and mature oligodendrocytes are affected in AD.
White matter abnormalities are increasingly recognized as important contributors to cognitive impairment in Alzheimer's disease, with oligodendrocyte lineage cells as key players.
- Reduced numbers: Decreased OPC density in white matter
- Impaired proliferation: Reduced response to demyelination
- Dysregulated differentiation: Failed maturation
- Premature death: Increased vulnerability
- NG2 downregulation: Surface proteoglycan loss
- PDGFRA changes: Altered receptor expression
- Sox10 dysregulation: Transcription factor changes
- Metabolic impairment: Energy failure
- Myelin breakdown: Structural degradation
- Lipid metabolism disruption: Critical for myelin
- Iron accumulation: Oxidative stress
- Energy deficit: High metabolic demand
- Amyloid deposition: Oligodendrocytes internalize Aβ
- Tau pathology: Found in oligodendrocytes (AGDs)
- White matter lesions: MRI-visible changes
- Oligodendrogliopathy: Primary pathology
- Thinning: Reduced myelin sheath thickness
- Beading: Irregular myelin structure
- Vacuolization: White matter edema
- Fragmentation: Distributed loss
- Conduction deficits: Slowed axonal transmission
- Axonal degeneration: Metabolic support loss
- Network dysfunction: Disconnection
- Hyperintensities: Leukoaraiosis
- Diffusion changes: Altered DTI metrics
- Atrophy: White matter volume loss
- Connectivity disruption: Functional impairment
- Periventricular: Early involvement
- Fronto-temporal: Clinical correlations
- Corpus callosum: Interhemispheric disconnection
- U-fibers: Subcortical changes
- OPC activation: Growth factor delivery
- Differentiation promotion: Cleavage molecules
- Metabolic support: Enhance function
- Anti-inflammatory: Reduce toxicity
- Antioxidant: Prevent oxidative damage
- Lipid supplementation: Support synthesis
- Stem cell therapy: OPC transplantation
- Gene therapy: Target delivery
- Rehabilitation: Activity-dependent repair
The study of Oligodendrocyte Lineage In Alzheimer'S Disease has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Bartzokis G. (2011). Alzheimer's disease as homeostatic responses to age-related myelin breakdown. Neurobiology of Aging.
- Desai MK, et al. (2010). Aberrant notch1, oligodendrocyte lineage in AD. Brain Pathology.
- Mifsud G, et al. (2021). Oligodendrocyte dysfunction in AD. Trends in Neurosciences.